You searched for Gout - Page 40 of 96

Abstract Number: 226 • 2016 ACR/ARHP Annual Meeting
Comparing the Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, UK, and USA
Puja Khanna¹, Eskinder Tafesse², Scott Baumgartner³, Anna Walker⁴ and Robert Morlock³, ¹Rheumatology, University of Michigan, Ann Arbor, MI, ²AstraZeneca Pharmaceuticals, Gaithersburg, MD, ³Ardea Biosciences, Inc., San Diego, CA, ⁴AstraZeneca Pharmaceuticals, Luton, United Kingdom
Background/Purpose: Less than 30% of gout patients achieve treatment targets and patients with tophi are less likely to achieve these goals than patients without tophi.…
Abstract Number: 227 • 2016 ACR/ARHP Annual Meeting
Inadequately Treated Chronic Gout As the Main Reason for Primary Gout Admission in an Urban Adult Population: Results of a Retrospective Cohort Study
Mandissa Sealey¹, Ibrahim Barry², Tanyka Sam¹, Olakanmi Awe¹ and Stuart Green³, ¹Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY, ²Internal Medicine, The Brooklyn Hospital Center, Bronx, NY, ³Internal Medicine, The Brooklyn Hospital Center, Larchmont, NY
Background/Purpose: Inadequately treated patients with chronic gout are at risk for an acute attack and many often require hospitalization. An acute attack of gout increases…
Abstract Number: 228 • 2016 ACR/ARHP Annual Meeting
Sick Leave and Disability Pension in Working-Age Gout Patients before and after Diagnosis – a Population Based Case-Control Study
Valgerdur R Sigurdardottir¹, Lennart TH Jacobsson², Panagiota Drivelegka², Anna Svärd^1,3 and Mats Dehlin², ¹Rheumatology Clinic, Falun Hospital, SE-791 82 Falun, Sweden, Falun, Sweden, ²Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, ³Center for Clinical Research Dalarna, Falun, Sweden
Background/Purpose: Gout is the most common form of inflammatory arthritis with a prevalence of 1.5% in our area in the age group 50-59 years. Gout…
Abstract Number: 229 • 2016 ACR/ARHP Annual Meeting
Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population
Michael Pillinger¹, Svetlana Krasnokutsky Samuels¹, Raymond Malamet², Bruce Schechter², Douglas CA Taylor³ and Robert Morlock⁴, ¹New York University, New York, NY, ²AstraZeneca, Gaithersburg, MD, ³Ironwood Pharmaceuticals, Cambridge, MA, ⁴Ardea Biosciences, Inc., San Diego, CA
Background/Purpose : Gout is the most prominent clinical manifestation of hyperuricemia, and is the most common cause of inflammatory arthritis. The symptoms of gout (eg,…
Abstract Number: 230 • 2016 ACR/ARHP Annual Meeting
A Survey of Knowledge of Optimal Gout Management in an Academic Primary Care Setting
Stefanie Wade¹ and Micha Abeles², ¹Medicine, University of Connecticut Health Center, Farmington, CT, ²Rheumatology, Consulting Rheumatologist, Midstate Medical Center, Meriden, CT
Background/Purpose: We reviewed previous treatment approaches for gout in patients referred to a university rheumatology practice for gout management. All patients met the 2015 American…
Abstract Number: 231 • 2016 ACR/ARHP Annual Meeting
Impact of an Educational Program for the Management of Gout Directed to Primary Care Physicians
Sandra Chinchilla¹, Irati Urionagüena¹ and Fernando Perez-Ruiz^1,2, ¹Rheumatology Division, Hospital Universitario Cruces, Baracaldo, Spain, ²BioCruces Health Research Institute, Baracaldo, Spain
Background/Purpose: Gout is the most frequent inflammatory arthritis in males, and therefore a common cause for consultation in both primary care and specialist settings. Despite…
Abstract Number: 232 • 2016 ACR/ARHP Annual Meeting
Impact of Gout Flare Prophylaxis and Urate-Lowering Therapy on Endothelial Function, Smooth Muscle Responsiveness and Markers of Inflammation: Results of a Prospective Observational Pilot Study
Talia Igel^1,2, Aaron Garza Romero², Virginia Pike³, Stuart Katz⁴, Binita Shah⁵, Irina Dektiarev⁴, Svetlana Krasnokutsky Samuels⁶ and Michael H. Pillinger⁷, ¹Monash University School of Medicine, Melbourne, Australia, ²Medicine/Rheumatology, NYU School of Medicine, New York, NY, ³Medicine/Rheumatology, NYU School of Medicine/NYU Hospital for Joint Diseases, New York, NY, ⁴Medicine/Cardiology, NYU School of Medicine, New York, NY, ⁵NYU School of Medicine, Division of Cardiology, New York, NY, ⁶Svetlana Krasnokutsky, NYU Hospital for Joint Diseases, New York, NY, ⁷NYU School of Medicine, New York, NY
Background/Purpose: To date, most studies of gout and cardiovascular disease have been cross-sectional or retrospective, and have addressed the outcome of acute coronary syndromes. Less…
Abstract Number: 233 • 2016 ACR/ARHP Annual Meeting
New Cardiovascular Risk Factors Screening in Patients with Gout
Juan Carlos Ordoñez¹, Mariano Andres¹, Francisca Sivera², Loreto Carmona³, Paloma Vela^4,5, Eliseo Pascual^4,5 and Jose Antonio Bernal⁴, ¹RHEUMATOLOGY, HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE, Alicante, Spain, ²RHEUMATOLOGY, HOSPITAL GENERAL UNIVERSITARIO DE ELDA, Elda, Spain, ³Instituto de Salud Musculo Esqueletica, Madrid, Spain, ⁴RHEUMATOLOGY, HOSPITAL GENERAL UNIVERSITARIO ALICANTE, Alicante, Spain, ⁵Medicina, Universidad Miguel Hernandez, Elche, Spain
Background/Purpose: Gout is a disease triggered by the crystallization of uric acid in the joints secondary to persistent hyperuricemia, that leads to chronic inflammation. Patients…
Abstract Number: 234 • 2016 ACR/ARHP Annual Meeting
Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality
Bryant R. England^1,2, Tina D. Mahajan³, Namrata Singh⁴, Brian W Coburn³, Grant W. Cannon⁵, Gail S. Kerr⁶, Andreas Reimold⁷, Angelo L. Gaffo⁸ and Ted R Mikuls⁹, ¹Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ²VA Nebraska-Western Iowa, Omaha, NE, ³Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, ⁴Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, ⁵Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ⁶Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ⁷Dallas VA Medical Center and University of Texas Southwestern Medical Center, Dallas, TX, ⁸Birmingham VA & University of Alabama at Birmingham, Birmingham, AL, ⁹Veteran Affairs Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Coexistent RA and gout were previously believed to be exceedingly rare due to several hypothesized mechanisms encompassing inhibition of crystal formation, deposition, and activation.…
Abstract Number: 294 • 2016 ACR/ARHP Annual Meeting
Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients with Medial Knee Osteoarthritis
Charles Oshinsky¹, Mukundan Attur², Sisi Ma³, Hua Zhou³, Fangfei Zheng¹, Meng Chen⁴, Jyoti Patel², Jonathan Samuels⁵, Virginia Pike⁶, Ravinder Regatte⁷, Jenny Bencardino⁸, Leon Rybak⁹, Steven B. Abramson¹⁰, Michael H. Pillinger¹¹ and Svetlana Krasnokutsky Samuels¹², ¹Medicine/Rheumatology, NYU School of Medicine, NEW YORK, NY, ²Rheumatology Research, NYU - Hospital for Joint Diseases, New York, NY, ³Bioinformatics, New York University, New York, NY, ⁴NYU School of Medicine, NEW YORK, NY, ⁵Division of Rheumatology, Department of Medicine, NYU Langone Medical Center, New York, NY, ⁶Medicine/Rheumatology, NYU School of Medicine/NYU Hospital for Joint Diseases, New York, NY, ⁷NYU Department of Radiology, NEW YORK, NY, ⁸Radiology, NYU Langone Medical Center, New York, NY, ⁹Department of Radiology, NYU Langone Medical Center, New York, NY, ¹⁰Dept of Rheumatology/Medicine, Hosp for Joint Diseases/NYU, New York, NY, ¹¹NYU School of Medicine, New York, NY, ¹²NYU School of Medicine, Division of Rheumatology, New York, NY
Background/Purpose: Osteoarthritis (OA) etiopathogenesis includes an inflammatory component. Published reports indicate that synovial fluid urate levels, even in patients without gout, associate with OA prevalence/severity.…
Abstract Number: 1013 • 2016 ACR/ARHP Annual Meeting
The Risk of Colchicine Associated Myopathy in Gout: Influence of Concomitant Use of Statin
Oh Chan Kwon¹, Byeongzu Ghang², Seokchan Hong³, Yong-Gil Kim⁴, Chang-Keun Lee³ and Bin Yoo⁴, ¹Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea, The Republic of, ²Division of Rheumatology, Department of Internal Medicine, Univerisy of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ³Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea, ⁴Division of Rheumatology, Department of Internal Medicine, University of Ulsan Collage of Medicine, Asan Medical Center, Seoul, South Korea
Background/Purpose: To investigate the risk of concomitant use of statin on the development of myopathy in gout patients who received colchicine. Methods: We included patients…
Abstract Number: 1148 • 2016 ACR/ARHP Annual Meeting
Implementation of a Gout Knowledge Based Assessment Tool in an Inter-Professional, Multi-Disciplinary Musculoskeletal Training Program
Erica Jaffe¹, Andrea M. Barker², Grant W. Cannon² and Michael J. Battistone², ¹Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ²Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT
Background/Purpose: The Musculoskeletal (MSK) Education Week is an interprofessional, multidisciplinary, multilevel training initiative launched in 2012. In 2015, this program was expanded to include a…
Abstract Number: 1157 • 2016 ACR/ARHP Annual Meeting
Using Goutpro to Make Medical Trainees Gout Pros
Linh Ngo¹, Peter A. Valen^2,3 and Alisa Duran⁴, ¹Division of Rheumatology, University of Minnesota, Minneapolis, MN, ²Medicine, Minneapolis VA Health Care System, Minneapolis, MN, ³Division of Rheumatology, University of Minnesota Medical School, Minneapolis, MN, ⁴Department of Medicine, University of Minnesota, Minneapolis, MN
Background/Purpose: Gout is the most common type of inflammatory arthritis in the U.S., affecting 4% of the population. Gout also has a large impact on…
Abstract Number: 1218 • 2016 ACR/ARHP Annual Meeting
Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities
Richard J. Reynolds¹, Marguerite Irvin², Gustavo de los Campos³, Hwasoon Kim³, Jasvinder Singh⁴ and Ana Vazquez³, ¹Medicine, University of Alabama at Birmingham, Birmingham, AL, ²Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ³Michigan State University, East Lansing, MI, ⁴University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Gout and hyperuricemia (serum urate > 7 mg/dL) typically present in the context of one or more comorbidities including type-2 diabetes, chronic renal disease,…
Abstract Number: 1225 • 2016 ACR/ARHP Annual Meeting
Serum Uric Acid Testing Practices over Five Years Among Incident Gout Cases
Dena H. Jaffe¹, Arriel Benis², Natalia M. Flores³, Hagit Gabay², Robert Morlock⁴, Alyssa Klein⁵, Dana Y Teltsch⁶, Jonathan Chapnick⁷, Becca Feldman², Yair Molad⁸, Shmuel M Giveon⁹ and Maya Leventer-Roberts², ¹Health Outcomes Research, Kantar Health, Jerusalem, Israel, ²Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel, ³Kantar Health, Foster City, CA, ⁴4939 Directors Place, Ardea Biosciences, Inc., San Diego, CA, ⁵AstraZeneca, Gaithersburg, MD, ⁶Evidera, Lexington, MA, ⁷Kantar Health, Horsham, PA, ⁸Rheumatology, Rabin Medical Center, Beilinson, Petah Tikva, Israel, ⁹Clalit Health Services, Tel Aviv, Israel
Background/Purpose: Gout is a chronic inflammatory disorder associated with elevated levels of serum uric acid (sUA), resulting in urate crystal deposits in soft tissues. Uncontrolled…

Comparing the Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, UK, and USA

Inadequately Treated Chronic Gout As the Main Reason for Primary Gout Admission in an Urban Adult Population: Results of a Retrospective Cohort Study

Sick Leave and Disability Pension in Working-Age Gout Patients before and after Diagnosis – a Population Based Case-Control Study

Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population

A Survey of Knowledge of Optimal Gout Management in an Academic Primary Care Setting

Impact of an Educational Program for the Management of Gout Directed to Primary Care Physicians

Impact of Gout Flare Prophylaxis and Urate-Lowering Therapy on Endothelial Function, Smooth Muscle Responsiveness and Markers of Inflammation: Results of a Prospective Observational Pilot Study

New Cardiovascular Risk Factors Screening in Patients with Gout

Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality

Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients with Medial Knee Osteoarthritis

The Risk of Colchicine Associated Myopathy in Gout: Influence of Concomitant Use of Statin

Implementation of a Gout Knowledge Based Assessment Tool in an Inter-Professional, Multi-Disciplinary Musculoskeletal Training Program

Using Goutpro to Make Medical Trainees Gout Pros

Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities

Serum Uric Acid Testing Practices over Five Years Among Incident Gout Cases

Simple Search Results